TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search

ARKG

ARK Genomic Revolution ETF

BATSETF
$42.91
+1.30%today

No SEC filings for this security

ARK Genomic Revolution ETF is a foreign or OTC-listed security (BATS) that doesn't file with the SEC, so the grounded research view — financials, filings, insider activity and the call — isn't available. Price and news only.

Key stats

52-week range$23.09 – $42.91
23.0952-week42.91
Volume
4.65M
1Y return
+76.58%
Beta
0.00

Price · 1Y

$42.91▲ +76.58%
over 1Y
L $23.09H $42.91

Recent news

market news →
Biotech ETFs Put Up Strong Show in 1H 2026: More Gains Ahead?Bullish
finance.yahoo.com· 2026-06-23
3 ETFs For the Coming Genomics RevolutionBullish
finance.yahoo.com· 2026-06-07
Thursday's ETF Movers: ARKG, TRFKBullish
nasdaq.com· 2026-06-04
Cathie Wood’s weekly update: Heavy buying in Bullish and Cerebras funded by sharp trims in Roku and AMDBullish
seekingalpha.com· 2026-05-25
Intellia Therapeutics Stock Is Down Nearly 95% From Its Record Highs but Cathie Wood Keeps BuyingBullish
finance.yahoo.com· 2026-05-05
Cathie Wood's weekly recap: pivots to XE nuclear play, Amazon, sells AMDBullish
seekingalpha.com· 2026-04-27
Cathie Wood Is Buying Up Alamar Biosciences Stock After Its IPO. Should You Snag Proteomics-Focused ALMR Too?Bullish
finance.yahoo.com· 2026-04-21
Cathie Wood's ARK boosts Palantir, Tesla, Roninhood bets; cuts semiconductor exposureBullish
seekingalpha.com· 2026-04-13

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.